American College of Gastroenterology 70th Annual Scientific Meeting
HONOLULU, October 31, 2005 -- A new study shows that treating Irritable Bowel Syndrome (IBS) with constipation may have a significant impact on absenteeism from work, as well as improving presenteeism defined as coming to work but being less productive. Canadian researchers from The University of Alberta and Novartis Pharmaceuticals Canada presented findings of a study of tegaserod in patients with IBS characterized by constipation at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
"IBS symptoms of abdominal pain or discomfort, bloating and constipation are associated with impaired quality of life and are the second most common cause of work-related absenteeism," according to Dr. Nigel Flook of the University of Alberta.
The study was conducted in a routine clinical practice setting with patients from 481 community physician sites across Canada. Researchers analyzed baseline data and survey responses at four and twelve weeks from 483 patients. They found that treatment with tegaserod was associated with a decrease in self-reported absenteeism in patients with symptoms of abdominal pain/discomfort, bloating and constipation: 27 percent of patients reported improvement in the number of days per month missed at school or work. Significant findings included improvements among approximately 50 percent of patients in the number of days per month when they accomplished less at school, work or home; while about 40 percent reported improvements in the number of days per month they had to cancel or reschedule activities because of their symptoms.
About Irritable Bowel Syndrome
IBS is a functional gastrointestinal (GI) disorder characterized by recurring symptoms of abdominal discomfort or pain associated with an altered bowel habit, either constipation, diarrhea, or both. More than 58 million people suffer from IBS, which affects
'"/>
31-Oct-2005
Page: 1 2 Related medicine news :1.
Study, meta-analysis examine factors associated with death from heatstroke2.
Study says COPD testing is not measuring up3.
Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms4.
Study reveals gaps in vaccine financing for underinsured children5.
Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks6.
Study shows radiofrequency ablation highly effective in treating kidney tumors7.
Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer8.
Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus9.
Study outlines how stroke, head injury can increase risk of Alzheimers disease10.
Study identifies new regulator of fat metabolism11.
Study shows Diachrome improves blood sugar control in people with type 2 diabetes